Pharmafile Logo
Pharmafocus logo
Advanced Search
clavis_pharma_nicholas_adams

Clavis Pharma appoints Nicholas Adams

July 13, 2011
Research and Development appointment, research and development

Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …

Appointment

Kantar Health Launches Global Health and Wellness Quarterly Update

July 12, 2011
Sales and Marketing Kantar Health, depression, emerging markets, information, newsletter, work productivity

The inaugural issue of Kantar Health’s Global Health and Wellness Update is now available. This is a quarterly newsletter sharing …

News
Press release
Sanofi's Multaq (dronedarone)

EMA widens safety review of Sanofi’s Multaq

July 12, 2011
Sales and Marketing Multaq, Sanofi

European regulators are to extend their assessment of the risks associated with Sanofi’s atrial fibrillation (AF) medicine Multaq to take …

News

Cellectis appoints Dr Andrew Scharenberg

July 12, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Paris-based genome engineering specialist Cellectis Therapeutics has appointed Dr Andrew Scharenberg as chief scientific officer. He is an attending physician …

Appointment

EMA plans adverse event reports for the public

July 12, 2011
Research and Development, Sales and Marketing EMA, adverse events, patient information

The EMA will start producing monthly adverse event reports for the public as part of its plans to open up …

News

New $50m plant unveiled by Kyowa Hakko Kirin

July 12, 2011
Manufacturing and Production Kyowa Hakko Kirin, pharma manufacturing news

Japan’s Kyowa Hakko Kirin is to build a new manufacturing unit for oral formulations at its main production facility in …

News

OctoPlus wins Danish development, manufacturing contract

July 12, 2011
Manufacturing and Production OctoPlus, pharma manufacturing news

Dutch drug delivery specialist OctoPlus has been awarded a contract with an unidentified Danish drugmaker based on its microsphere technology. …

News

Lonza buys Arch Chemicals for $1.2 billion

July 12, 2011
Manufacturing and Production Lonza, pharma manufacturing news

Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …

News

Takeda forced to withdraw Actos in France

July 11, 2011
Sales and Marketing Actos, Competact, Takeda, diabetes

Takeda has officially taken its diabetes drug Actos off the market in France at the request of the country’s medicines …

News

Cadila plant in India gets FDA warning

July 11, 2011
Manufacturing and Production Cadila, FDA warning letter, pharma manufacturing news

Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …

News

Chiltern Announces New Legal Entity in Israel

July 11, 2011
Research and Development

 

News
Press release

Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost

July 11, 2011
Sales and Marketing Lipitor, Pfizer, paediatric trials

Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …

News
Sanofi

Sanofi sells dermatology unit for $425m

July 11, 2011
Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi, Valeant, dermatology

Sanofi has sold its Canadian dermatology unit Dermik for $425 million in order to concentrate on key growth areas like …

News
idea_pharma_louisa_roberts

Lousia Roberts and Ralph Torbay join Idea Pharma

July 11, 2011
Sales and Marketing appointment, sales and marketing

Idea Pharma has two new additions to its team, appointing Louisa Roberts and Ralph Torbay. Louise joins the phase II …

Appointment

Novartis’ Votubia reduces benign brain tumours in SEGA patients

July 11, 2011
Research and Development Novartis, SEGA, Votubia, everolimus

Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …

News

Kantar Health Names Werner Guminski CEO, Commercial Strategy

July 8, 2011
Business Services, Research and Development Kantar Health, commercial strategy

Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …

News
Press release

Publicis Life Brands Resolute boosts team

July 8, 2011
Medical Communications appointment, medical communications, medical communications news, publicis

London-based healthcare communications agency Publicis Life Brands Resolute has boosted its Creative and Digital division with four new appointments. They …

News

Ferring relocates to new UK headquarters

July 8, 2011
Sales and Marketing Ferring, UK pharma

Ferring Pharmaceuticals has moved its UK operations from Slough to new facilities just outside London in West Drayton. The Swiss …

News

Lilly chief: German reforms jeopardise pharma innovation

July 8, 2011
Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing

German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …

News

Pfizer sharpens its pharma focus

July 8, 2011
Sales and Marketing Pfizer, animal health, nutrition, pharma strategy

Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026